相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Whole-genome sequencing of East Asian lung cancers reveals new germline pathogenic variants
Semanti Mukherjee et al.
CANCER CELL (2022)
Tumor Microenvironment: A Metabolic Player that Shapes the Immune Response
Shamir Cassim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Lactate in Sarcoma Microenvironment: Much More than just a Waste Product
Maria Letizia Taddei et al.
CELLS (2020)
Immune checkpoints in hematologic malignancies: What made the immune cells and clinicians exhausted!
Abbas Hajifathali et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma
Kristiina Karihtala et al.
CANCERS (2020)
Amino Assests: How Amino Acids Support Immunity
Beth Kelly et al.
CELL METABOLISM (2020)
Breast cancer: Biology, biomarkers, and treatments
Khadijeh Barzaman et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Manipulation of Metabolic Pathways and Its Consequences for Anti-Tumor Immunity: A Clinical Perspective
Huang-Yu Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells
Fabio Morandi et al.
CELLS (2020)
Association of TIM-3 expression with glucose metabolism in Jurkat T cells
Mi Jin Lee et al.
BMC IMMUNOLOGY (2020)
Prognostic and clinicopathological value of high expression of TIM-3 in different cancer types: A meta-analysis
Wenbo Xu et al.
PRECISION MEDICAL SCIENCES (2020)
Overexpression of bHLH domain of HIF-1 failed to inhibit the HIF-1 transcriptional activity in hypoxia
Fatemeh Sadeghi et al.
BIOLOGICAL RESEARCH (2020)
Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors
Kyung Hae Jung et al.
CLINICAL CANCER RESEARCH (2019)
Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
Xiaoyun Li et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Control of the Antitumor Immune Response by Cancer Metabolism
Charlotte Domblides et al.
CELLS (2019)
A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer
Johanna Wagner et al.
CELL (2019)
Predictive biomarkers for PD-1 and PD-L1 immune checkpoint blockade therapy
Yue Song et al.
IMMUNOTHERAPY (2019)
Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance
Ladan Mashouri et al.
MOLECULAR CANCER (2019)
A Truncated Snail1 Transcription Factor Alters the Expression of Essential EMT Markers and Suppresses Tumor Cell Migration in a Human Lung Cancer Cell Line
Mohammad Davoodzadeh Gholami et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2019)
Lymphocyte Activation Gene-3 Maintains Mitochondrial and Metabolic Quiescence in Naive CD4+ T Cells
Dana M. Previte et al.
CELL REPORTS (2019)
Macrophages and Metabolism in the Tumor Microenvironment
Ilio Vitale et al.
CELL METABOLISM (2019)
Targeting the tumor microenvironment and T cell metabolism for effective cancer immunotherapy
Helen Carrasco Hope et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma
Malgorzata Czystowska-Kuzmicz et al.
NATURE COMMUNICATIONS (2019)
Novel Immunotherapy Combinations
Babar Bashir et al.
CURRENT ONCOLOGY REPORTS (2019)
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy
Kathrin Renner et al.
CELL REPORTS (2019)
Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients
Qinchuan Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
Karen G. de la Cruz-Lopez et al.
FRONTIERS IN ONCOLOGY (2019)
CD73 as a potential opportunity for cancer immunotherapy
Ghasem Ghalamfarsa et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Myeloid-derived suppressor cells and tumor: Current knowledge and future perspectives
Elahe Safari et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?
Maartje G. Schouwenburg et al.
CANCERS (2019)
Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events
Yoshiyuki Nakamura
FRONTIERS IN MEDICINE (2019)
Metabolic interventions in the immune response to cancer
David O'Sullivan et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma
Duaa O. Khair et al.
FRONTIERS IN IMMUNOLOGY (2019)
Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer
Mohammad H. Kazemi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma
Zachary J. Brown et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Let-7 Suppresses B Cell Activation through Restricting the Availability of Necessary Nutrients
Shuai Jiang et al.
CELL METABOLISM (2018)
Research of novel anticancer agents targeting arginase inhibition
Thanh-Nhat Pham et al.
DRUG DISCOVERY TODAY (2018)
Investigation of the Cellular Immune Response to Recombinant Fragments of Filamentous Hemagglutinin and Pertactin of Bordetella pertussis in BALB/c Mice
Peyman Bakhshaei et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2018)
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
John M. Wrangle et al.
LANCET ONCOLOGY (2018)
Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma
Yucheng Fu et al.
MEDICINE (2018)
The impact of tumor cell metabolism on T cell-mediated immune responses and immuno-metabolic biomarkers in cancer
Gregory Noel et al.
SEMINARS IN CANCER BIOLOGY (2018)
Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy
Adam J. Wolpaw et al.
TRENDS IN CELL BIOLOGY (2018)
Metabolic Control of CD8+ T Cell Fate Decisions and Antitumor Immunity
Lianjun Zhang et al.
TRENDS IN MOLECULAR MEDICINE (2018)
Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice
Roisin M. Loftus et al.
NATURE COMMUNICATIONS (2018)
Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
Muhammad Zubair Afzal et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Targeting adenosine for cancer immunotherapy
Robert D. Leone et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Impact of L-Arginine Metabolism on Immune Response and Anticancer Immunotherapy
Sun-Hee Kim et al.
FRONTIERS IN ONCOLOGY (2018)
Immunometabolism in cancer at a glance
Katrin Singer et al.
DISEASE MODELS & MECHANISMS (2018)
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
Tara C. Mitchell et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Metabolic Checkpoints: Novel Avenues for Immunotherapy of Cancer
Ivan Shevchenko et al.
FRONTIERS IN IMMUNOLOGY (2018)
Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism
Marc O. Johnson et al.
CELL (2018)
Increased Levels of Branched-Chain Amino Acid Associated With Increased Risk of Pancreatic Cancer in a Prospective Case-Control Study of a Large Cohort
Ryoko Katagiri et al.
GASTROENTEROLOGY (2018)
Lactate at the crossroads of metabolism, inflammation, and autoimmunity
Valentina Pucino et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Cancer metabolism: a therapeutic perspective
Ubaldo E. Martinez-Outschoorn et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
A molecular and preclinical comparison of the PD-1-targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab
Petros Fessas et al.
SEMINARS IN ONCOLOGY (2017)
Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors
Eva M. Palsson-McDermott et al.
FRONTIERS IN IMMUNOLOGY (2017)
Metabolic Hallmarks of Tumor and immune Cells in the Tumor Microenvironment
Kathrin Renner et al.
FRONTIERS IN IMMUNOLOGY (2017)
Safety and clinical activity of adenosine A2a receptor (A2aR) antagonist, CPI-444, in anti-PD1/PDL1 treatment-refractory renal cell (RCC) and non-small cell lung cancer (NSCLC) patients.
Lawrence Fong et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Incorporating Oxygen-Enhanced MRI into Multi-Parametric Assessment of Human Prostate Cancer
Heling Zhou et al.
DIAGNOSTICS (2017)
Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms
Mohammad Davoodzadeh Gholami et al.
CELLULAR IMMUNOLOGY (2017)
CD155T/TIGIT Signaling Regulates CD8+ T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer
Weiling He et al.
CANCER RESEARCH (2017)
Srebp-controlled glucose metabolism is essential for NK cell functional responses
Nadine Assmann et al.
NATURE IMMUNOLOGY (2017)
M2-like macrophage polarization in high lactic acid-producing head and neck cancer
Toshimitsu Ohashi et al.
CANCER SCIENCE (2017)
Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors
Gabriela Andrejeva et al.
CELL METABOLISM (2017)
Intrinsic Resistance of Solid Tumors to Immune Checkpoint Blockade Therapy
Xianda Zhao et al.
CANCER RESEARCH (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy
Shari Pilon-Thomas et al.
CANCER RESEARCH (2016)
Immune Checkpoint Inhibitors: An Introduction to the Next-Generation Cancer Immunotherapy
Lucy Lee et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
PF-06840003: a highly selective IDO-1 inhibitor that shows good in vivo efficacy in combination with immune checkpoint inhibitors
Joseph Tumang et al.
CANCER RESEARCH (2016)
Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α
Sangbin Lim et al.
CANCER RESEARCH (2016)
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Roger Geiger et al.
CELL (2016)
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Almut Brand et al.
Cell Metabolism (2016)
Metabolic pathways in T cell activation and lineage differentiation
Luis Almeida et al.
SEMINARS IN IMMUNOLOGY (2016)
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2016)
Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors
Caroline E. Nunes-Xavier et al.
ONCOTARGET (2016)
Strategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyond
Cristina Migali et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2016)
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
Lucas B. Sullivan et al.
NATURE REVIEWS CANCER (2016)
Regulatory circuits of T cell function in cancer
Daniel E. Speiser et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment
Sara Serra et al.
BLOOD ADVANCES (2016)
A guide to immunometabolism for immunologists
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation
Maria Ida Malandrino et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
Gene Expression Signatures as Biomarkers of Tumour Hypoxia
B. H. L. Harris et al.
CLINICAL ONCOLOGY (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Immune-mediated antitumor effect by type 2 diabetes drug, metformin
Shingo Eikawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation
Dorota Klysz et al.
SCIENCE SIGNALING (2015)
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
Nikolaos Patsoukis et al.
NATURE COMMUNICATIONS (2015)
B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer
Yixiang Mao et al.
ONCOTARGET (2015)
LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model
Ruea-Yea Huang et al.
ONCOTARGET (2015)
Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation
Dorota Klysz et al.
SCIENCE SIGNALING (2015)
Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models
Jessica Spahn et al.
Journal for ImmunoTherapy of Cancer (2015)
A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy
Robert D. Leone et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2015)
Extracellular vesicles: potential applications in cancer diagnosis, prognosis, and epidemiology
Mukesh Verma et al.
BMC CLINICAL PATHOLOGY (2015)
Network Integration of Parallel Metabolic and Transcriptional Data Reveals Metabolic Modules that Regulate Macrophage Polarization
Abhishek K. Jha et al.
IMMUNITY (2015)
L-Arginine and its metabolites in kidney and cardiovascular disease
Ada Popolo et al.
AMINO ACIDS (2014)
Circulating Biomarkers of Tryptophan and the Kynurenine Pathway and Lung Cancer Risk
Shu-Chun Chuang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
Ivraym B. Barsoum et al.
CANCER RESEARCH (2014)
VISTA Is an Immune Checkpoint Molecule for Human T Cells
J. Louise Lines et al.
CANCER RESEARCH (2014)
Indoleamine 2,3-dioxygenase promotes peritoneal metastasis of ovarian cancer by inducing an immunosuppressive environment
Yuko Tanizaki et al.
CANCER SCIENCE (2014)
HeteSim: A General Framework for Relevance Measure in Heterogeneous Networks
Chuan Shi et al.
IEEE TRANSACTIONS ON KNOWLEDGE AND DATA ENGINEERING (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Memory CD8+ T Cells Use Cell-Intrinsic Lipolysis to Support the Metabolic Programming Necessary for Development
David O'Sullivan et al.
IMMUNITY (2014)
Glucose-dependent de Novo Lipogenesis in B Lymphocytes A REQUIREMENT FOR ATP-CITRATE LYASE IN LIPOPOLYSACCHARIDE-INDUCED DIFFERENTIATION
Fay J. Dufort et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
PD-L1 is a novel direct target of HIF-1α., and its blockade under hypoxia enhanced MDSC-mediated T cell activation
Muhammad Zaeem Noman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function
Raymond P. Donnelly et al.
JOURNAL OF IMMUNOLOGY (2014)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Oscar R. Colegio et al.
NATURE (2014)
TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKε supports the anabolic demands of dendritic cell activation
Bart Everts et al.
NATURE IMMUNOLOGY (2014)
De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells
Luciana Berod et al.
NATURE MEDICINE (2014)
Phase 1/2 trial of the indoleamine 2,3-dioxygenase pathway (IDO) inhibitor indoximod plus ipilimumab for the treatment of unresectable stage 3 or 4 melanoma
Eugene Kennedy et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Metabolic Regulation of T Lymphocytes
Nancie J. MacIver et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Mitochondria Are Required for Antigen-Specific T Cell Activation through Reactive Oxygen Species Signaling
Laura A. Sena et al.
IMMUNITY (2013)
Metabolic Pathways in Immune Cell Activation and Quiescence
Erika L. Pearce et al.
IMMUNITY (2013)
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
G. M. Tannahill et al.
NATURE (2013)
Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch
Patrick M. Gubser et al.
NATURE IMMUNOLOGY (2013)
Mechanisms of triglyceride accumulation in activated macrophages
Kenneth R. Feingold et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
ACCELERATED PUBLICATION The mitochondrial citrate carrier: a new player in inflammation
Vittoria Infantino et al.
BIOCHEMICAL JOURNAL (2011)
Evaluation of the immunomodulatory effect of the 14 kDa protein isolated from aged garlic extract on dendritic cells
Hasan Namdar Ahmadabad et al.
CELLULAR IMMUNOLOGY (2011)
Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)
Ariel C. Bulua et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
HIF1α-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
Lewis Z. Shi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
Ryan D. Michalek et al.
JOURNAL OF IMMUNOLOGY (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Role of CD73 and extracellular adenosine in disease
Simon C. Robson
PURINERGIC SIGNALLING (2011)
Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation
Connie M. Krawczyk et al.
BLOOD (2010)
Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells
D. Eastwood et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression
Andrew L. Doedens et al.
CANCER RESEARCH (2010)
The mTOR Kinase Determines Effector versus Memory CD8+ T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin
Rajesh R. Rao et al.
IMMUNITY (2010)
Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation
Juan-Carlos Rodriguez-Prados et al.
JOURNAL OF IMMUNOLOGY (2010)
Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes
Josef Ecker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Serum and Tissue LDH Levels in Patients with Breast/Gynaecological Cancer and Benign Diseases
Michael I. Koukourakis et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2009)
The significance of OX40 and OX40L to T-cell biology and immune disease
Michael Croft et al.
IMMUNOLOGICAL REVIEWS (2009)
Lipid synthesis in macrophages during inflammation in vivo:: Effect of agonists of peroxisome proliferator activated receptors α and γ and of retinoid X receptors
E. N. Posokhova et al.
BIOCHEMISTRY-MOSCOW (2008)
Hyperpolarized 13C Lactate, Pyruvate, and Alanine: Noninvasive Biomarkers for Prostate Cancer Detection and Grading
Mark J. Albers et al.
CANCER RESEARCH (2008)
A Personalized Approach to Cancer Treatment: How Biomarkers Can Help
Michael J. Duffy et al.
CLINICAL CHEMISTRY (2008)
Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma
Ke Pan et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Re-educating tumor-associated macrophages by targeting NF-κB
Thorsten Hagemann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues
D. Lukashev et al.
CANCER AND METASTASIS REVIEWS (2007)
GITR/GITRL: More than an effector T cell co-stimulatory system
Giuseppe Nocentini et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Pharmacokinetics and safety of arginine supplementation in animals
Guoyao Wu et al.
JOURNAL OF NUTRITION (2007)
Increased expression of hypoxia-inducible factor 1 alpha in type I and type II endometrial carcinomas
Vaishali Pansare et al.
MODERN PATHOLOGY (2007)
Expression of hypoxia-inducible factor (HIF)-1α as a biomarker of outcome in soft-tissue sarcomas
Ken Shintani et al.
VIRCHOWS ARCHIV (2006)
Inflammation and insulin resistance
Steven E. Shoelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer:: Effect on tumor-infiltrating T cells
G Brandacher et al.
CLINICAL CANCER RESEARCH (2006)
Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth
Cheryl A. Doughty et al.
BLOOD (2006)
Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium
P Casanello et al.
CIRCULATION RESEARCH (2005)
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers
V Bronte et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses
PC Rodriguez et al.
CANCER RESEARCH (2004)
Lactate: Mirror and motor of tumor malignancy
S Walenta et al.
SEMINARS IN RADIATION ONCOLOGY (2004)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Elevated serum arginase activity levels in patients with breast cancer
MF Polat et al.
SURGERY TODAY (2003)
Serum arginase activity in postsurgical monitoring of patients with colorectal carcinoma
Z Porembska et al.
CANCER (2002)
Arginase isoforms in human colorectal cancer
Z Porembska et al.
CLINICA CHIMICA ACTA (2001)
分享论文
